Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination dietary supplement containing **Bacopa monnieri**, **Coffea arabica** (typically as whole coffee fruit extract), and **Panax quinquefolius** (American ginseng). This formulation is used as a nootropic to support cognitive function, improve working memory, and enhance mental performance. Bacopa monnieri is known for its neuroprotective and memory-enhancing properties thought to involve modulation of neurotransmission and antioxidant activity. Coffea arabica provides polyphenols and caffeine, contributing to increased alertness and modulation of neurotrophic factors such as brain-derived neurotrophic factor (BDNF). Panax quinquefolius is included for its adaptogenic and cognitive-supporting effects, believed to be mediated via ginsenoside-induced modulation of central nervous system signaling and immune support. This specific combination has shown in randomized placebo-controlled trials improvement in working memory performance, delayed recall, and positive affect, with evidence of improved cerebral cortex activation during cognitive tasks in healthy adults[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bacopa monnieri + coffea arabica + panax quinquefolius.